195 related articles for article (PubMed ID: 16390818)
1. Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels.
Motlekar NA; Srivenugopal KS; Wachtel MS; Youan BB
J Drug Target; 2005 Dec; 13(10):573-83. PubMed ID: 16390818
[TBL] [Abstract][Full Text] [Related]
2. Modulation of gastrointestinal permeability of low-molecular-weight heparin by L-arginine: in-vivo and in-vitro evaluation.
Motlekar NA; Srivenugopal KS; Wachtel MS; Youan BB
J Pharm Pharmacol; 2006 May; 58(5):591-8. PubMed ID: 16640827
[TBL] [Abstract][Full Text] [Related]
3. Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.
Motlekar NA; Fasano A; Wachtel MS; Youan BB
J Drug Target; 2006 Jun; 14(5):321-9. PubMed ID: 16882552
[TBL] [Abstract][Full Text] [Related]
4. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
[TBL] [Abstract][Full Text] [Related]
5. Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs.
Raoof AA; Ramtoola Z; McKenna B; Yu RZ; Hardee G; Geary RS
Eur J Pharm Sci; 2002 Nov; 17(3):131-8. PubMed ID: 12393140
[TBL] [Abstract][Full Text] [Related]
6. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
7. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions.
Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ
Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer.
Motlekar NA; Srivenugopal KS; Wachtel MS; Youan BB
Drug Dev Res; 2006 Feb; 67(2):166-174. PubMed ID: 17710191
[TBL] [Abstract][Full Text] [Related]
9. Tetradecylmaltoside (TDM) enhances in vitro and in vivo intestinal absorption of enoxaparin, a low molecular weight heparin.
Yang T; Arnold JJ; Ahsan F
J Drug Target; 2005 Jan; 13(1):29-38. PubMed ID: 15848952
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine.
Lv XY; Li J; Zhang M; Wang CM; Fan Z; Wang CY; Chen L
AAPS PharmSciTech; 2010 Mar; 11(1):372-82. PubMed ID: 20237966
[TBL] [Abstract][Full Text] [Related]
11. In situ intestinal absorption studies on low molecular weight heparin in rats using labrasol as absorption enhancer.
Rama Prasad YV; Minamimoto T; Yoshikawa Y; Shibata N; Mori S; Matsuura A; Takada K
Int J Pharm; 2004 Mar; 271(1-2):225-32. PubMed ID: 15129989
[TBL] [Abstract][Full Text] [Related]
12. Intestinal absorption of low molecular weight heparin in animals and human subjects.
Nissan A; Ziv E; Kidron M; Bar-On H; Friedman G; Hyam E; Eldor A
Haemostasis; 2000; 30(5):225-32. PubMed ID: 11251329
[TBL] [Abstract][Full Text] [Related]
13. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
14. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
[TBL] [Abstract][Full Text] [Related]
15. Intestinal transport of 3,6'-disinapoylsucrose, a major active component of Polygala tenuifolia, using Caco-2 cell monolayer and in situ rat intestinal perfusion models.
Chen Y; Liu X; Pan R; Zhu X; Steinmetz A; Liao Y; Wang N; Peng B; Chang Q
Planta Med; 2013 Oct; 79(15):1434-9. PubMed ID: 24043590
[TBL] [Abstract][Full Text] [Related]
16. Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo.
Thanou M; Nihot MT; Jansen M; Verhoef JC; Junginger HE
J Pharm Sci; 2001 Jan; 90(1):38-46. PubMed ID: 11064377
[TBL] [Abstract][Full Text] [Related]
17. Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.
Maher S; Medani M; Carballeira NN; Winter DC; Baird AW; Brayden DJ
AAPS J; 2017 Jan; 19(1):244-253. PubMed ID: 27739012
[TBL] [Abstract][Full Text] [Related]
18. Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route.
Anderberg EK; Lindmark T; Artursson P
Pharm Res; 1993 Jun; 10(6):857-64. PubMed ID: 8321854
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity of absorption enhancers in Caco-2 cell monolayers.
Sakai M; Imai T; Ohtake H; Otagiri M
J Pharm Pharmacol; 1998 Oct; 50(10):1101-8. PubMed ID: 9821655
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic.
Maher S; Leonard TW; Jacobsen J; Brayden DJ
Adv Drug Deliv Rev; 2009 Dec; 61(15):1427-49. PubMed ID: 19800376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
